Loading clinical trials...
Loading clinical trials...
A Phase 1, Open Label, Fixed Sequence Study To Investigate The Effect Of Multiple Doses Of PF-04531083 On Simvastatin And Simvastatin Acid Pharmacokinetics Following Single Dose Of Simvastatin in Healthy Volunteers
The purpose of this study is to quantify the effect of multiple doses of PF-04531083 on the pharmacokinetics (PK) of co-administered single dose simvastatin.
observational- quantify any effects of PF\_04531083 on the PK of Simvastatin
Age
18 - 45 years
Sex
ALL
Healthy Volunteers
Yes
Pfizer Investigational Site
Brussels, Belgium
Start Date
March 1, 2010
Primary Completion Date
May 1, 2010
Completion Date
May 1, 2010
Last Updated
June 4, 2010
24
ACTUAL participants
PF-04531083
DRUG
simvastatin
DRUG
PF-04531083
DRUG
simvastatin
DRUG
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06219408